[1] Yano M, Omoto Y, Yamakawa Y, et al. Increased matrix metalloproteinase 9 activity and mRNA expression in lung ischemia-reperfusion injury[J]. Heart Lung Transplant, 2001, 20(6): 679-686. [2] Yeh DY, Lin HI, Feng NH, et al. Matrix metalloprotease expressions in both reperfusion lung injury and oleic acid lung injury models and the protective effects of ilomastat[J]. Transplant Proc, 2009, 41(5): 1508-1511. [3] Shimoyama T, Tabuchi N, Chung J, et al. Matrix metalloproteinase inhibitor (ONO-4817) attenuates ischemia-reperfusion injury in rat lung [J]. Med Sci Monit, 2006, 12(2): BR51- BR56. [4] Sommer SP, Sommer S, Sinha B, et al. Ischemia-reperfusion injury-induced pulmonary mitochondrial damage [J]. Heart Lung Transplant, 2011, 30(7): 811-818. [5] Dejonckheere E, Vandenbroucke RE, Libert C. Matrix metalloproteinases as drug targets in ischemia/ reperfusion injury[J]. Drug Discov Today, 2011, 16(17/18): 762-778. [6] 王莉. 基质金属蛋白酶抑制剂的筛选的研究[D]. 南京: 东南大学基础医学院. [7] 陶冬英, 陈平圣, 刘东风. 季德胜蛇药片对大鼠急性肺损伤的保护作用[J]. 中华急诊医学杂志, 2006, 15(3): 223-227. [8] Eppinger MJ, Deeb GM, Bolling SF, et al. Mediators of ischemia-reperfusion injury of rat lung[J]. Am J Pathol, 1997, 150(5): 1773-1784. [9] 陶冬英. 季德胜蛇药片对大鼠ALI/ARDS的预防作用研究[D]. 南京: 东南大学基础医学院. [10] 司裕龙, 张文凯. 重组人白介素-10对大鼠肺缺血再灌注损伤的保护作用[J]. 中国临床药理学与治疗学, 2011, 16(11): 1239-1243. [11] 贾伟伟, 李慧. 依达拉奉预处理对兔肺缺血再灌注损伤后肺水肿的影响[J]. 中国现代医生, 2013, 51(1): 1-7. [12] Torii K, Iida K, Miyazaki Y, et al. Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome[J]. Am J Respir Crit Care Med, 1997, 155(1): 43-46. [13] 丁丽娟, 汤伟, 汪晓, 等. 季德胜蛇药对大鼠急性肝损伤的保护作用及机制的初步研究[J]. 交通医学, 2009, 23(1): 5-8. [14] 刘永平, 曾治平. 多西环素减轻小鼠内毒素性急性肺损伤的作用及机制研究[J]. 中国临床药理学与治疗学, 2009, 14(10): 1133-1136. [15] 罗海燕, 孙宗全, 蒋雄刚, 等. 基质金属蛋白酶抑制剂对肺缺血再灌注损伤的保护作用[J]. 华中科技大学学报:医学版, 2007, 36 (2): 206-209. |